AARD Stock Analysis: Buy, Sell, or Hold?
AARD - Aardvark Therapeutics, Inc. Common Stock
$12.99
-0.36 (-2.70%)
▼
5d:
-13.46%
30d:
-1.78%
90d:
+13.25%
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Apr 06, 2026
Get Alerted When AARD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: AARD is down 13.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: AARD is down 13.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: AARD is currently trading at $12.99, which is considered oversold relative to its 30-day fair value range of $13.33 to $15.18.
Technical Outlook: Technically, AARD is in a uptrend. Immediate support is located at $12.43, while resistance sits at $16.60.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $32.64 (+151.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AARD is in a uptrend. Immediate support is located at $12.43, while resistance sits at $16.60.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $32.64 (+151.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$13.33 -
$15.18
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 151.2% below Wall St target ($32.64)
- WARNING: Recommendation downgraded due to -13.5% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$13.33 -
$15.18
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$12.43
Resistance Level
$16.60
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-3.62
Wall Street Target
$32.64
(+151.2%)
Last updated: February 02, 2026 8:54 AM ET
Data refreshes hourly during market hours. Next update: 9:54 AM
Data refreshes hourly during market hours. Next update: 9:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AARD showing a specific setup today?
Insider Activity (6 Months)
5
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Tien-Li Lee
BUY
10000 shares
2025-09-15
Tien-Li Lee
BUY
5000 shares
2025-09-12
Tien-Li Lee
BUY
6000 shares
2025-09-11
Featured in Portfolios
AARD is a key holding in these high-performance investment strategies.
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1036 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$85 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
